[The risk of endocrine activation in interventional procedures on paraganglioma of the head and neck].
In the literature on paragangliomas or glomus tumors of the head and neck, the question rarely arises as to whether in endocrine inactive paragangliomas the tumor necrosis resulting from the embolization can release the stored substances. Based on 34 paragangliomas after surgical treatment, the angiographic and immunohistological characteristics of the paraganglionic, angiomatous and adenomatous tumors are presented. No catecholamine secretion occurred as a result of interventional or surgical treatment.
Kretzschmar
K
K
Abteilung für Neuroradiologie, Universitätskliniken Mainz.
Milewski
C
C
Dienes
H P
HP
D000912:Antibodies, Neoplasm / Q000032:analysis; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D005260:Female; D005925:Glomus Jugulare Tumor / Q000378:metabolism / Q000601:surgery / Q000628:therapy; D006258:Head and Neck Neoplasms / Q000378:metabolism* / Q000601:surgery / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010236:Paraganglioma, Extra-Adrenal / Q000378:metabolism* / Q000601:surgery / Q000628:therapy; D010579:Petrous Bone; D010751:Phosphopyruvate Hydratase / Q000276:immunology; D012307:Risk Factors; D009418:S100 Proteins / Q000276:immunology; D012888:Skull Neoplasms / Q000378:metabolism / Q000601:surgery / Q000628:therapy
D000912:Antibodies, Neoplasm; D009418:S100 Proteins; D010751:Phosphopyruvate Hydratase
Das Risiko der endokrinen Aktivierung bei interventionellen Eingriffen an Paragangliomen des Kopf-Hals-Bereiches.